The Best Hair Transplant Surgeons in the World: 2026 AHLA Guide
INTRODUCTION Medically reviewed by Aron G. Nusbaum, M.D., FAAD – April 28, 2026 There
The Bald Truth Podcast
In 1998, Spencer Kobren made broadcasting history with the launch of Spencer Kobren’s The Bald Truth, the first radio program dedicated exclusively to hair loss, its prevention and treatment, and the profound emotional impact the condition can have on those affected. Originally broadcast on New York City’s legendary WABC Radio, the program broke new ground by addressing a subject that had long been trivialized, misunderstood or dismissed by mainstream society. For the first time, people struggling with hair loss had a public forum where they could speak openly about their experiences, learn about legitimate treatment options and discover that they were not alone.
Beyond providing access to credible medical information and leading physicians, The Bald Truth gave listeners a voice. Men and women from all walks of life shared how hair loss affected their self-confidence, personal relationships, professional interactions and even their ability to feel comfortable in their own skin. These were deeply personal experiences that society rarely acknowledged as legitimate concerns. Male pattern baldness was, and in many ways remains, an acceptable target of public ridicule, while female pattern hair loss continues to be widely misunderstood and underrecognized. By bringing these conversations into the open, the program helped challenge the stigma surrounding hair loss and established a community built on understanding, education and mutual support.
Following the events of September 11, 2001, Kobren relocated from New York to Los Angeles, where The Bald Truth continued its expansion into national syndication. Broadcasting from Westwood One Radio’s studios in Culver City, California, the program ultimately reached 27 radio markets across the United States, while its presence on XM Satellite Radio extended its reach to an international audience throughout North America. What began as a groundbreaking New York radio show had evolved into an internationally recognized platform for hair loss education, patient advocacy and consumer protection.
Today, Spencer Kobren’s The Bald Truth continues as the longest-running program of its kind, bringing nearly three decades of experience and perspective to the modern hair restoration conversation. Joined by fellow hair restoration advocate Joe Tillman, Kobren examines established medical treatments, emerging therapies, advances in hair transplant surgery and the increasingly aggressive marketing practices that influence patients seeking solutions. Their unscripted discussions draw on decades of direct involvement in the field, challenging questionable claims while continuing to address the emotional realities of living with hair loss.
From its earliest broadcasts to its present-day digital format, the mission of Spencer Kobren’s The Bald Truth has remained unchanged: to provide people experiencing hair loss with a place where their concerns are taken seriously, their experiences are understood and they can obtain the information and perspective necessary to make informed decisions about their lives and treatment options.
Watch Spencer Kobren’s The Bald Truth live every Friday at 3 PM Pacific / 6 PM Eastern on the Hair Transplant Channel.
Follow Spencer Kobren on Instagram: @spencerkobren
Can Ozempic and Other Weight Loss Drugs Cause Hair Loss?
GLP-1 medications such as Ozempic, Wegovy and Zepbound have raised questions about their potential effects on hair growth. Is the shedding experienced by some patients temporary, or could underlying androgenetic alopecia also be involved?
In this episode of Spencer Kobren’s The Bald Truth, Kobren and Joe Tillman examine emerging research concerning GLP-1 medications and hair loss, including the distinction between telogen effluvium and progressive pattern hair loss. The discussion highlights why understanding the underlying cause of hair shedding is essential before making decisions about medical treatment or surgical hair restoration.
Is 22 Too Young for a Hair Transplant?
Hair transplant surgery can produce natural results in appropriate candidates, but undergoing transplantation too young may create permanent cosmetic problems as androgenetic alopecia progresses. A hairline that looks attractive at 22 may become increasingly difficult to maintain by 35.
Spencer Kobren and Joe Tillman examine the risks of premature surgery, aggressive donor harvesting and inadequate long term planning. The discussion emphasizes the importance of evaluating future hair loss, preserving limited donor resources and determining whether medical treatment or postponing surgery may offer a more responsible approach.
Is RU58841 Safe for Hair Loss? The Risks of an Unapproved Treatment
RU58841 is an experimental topical antiandrogen that has gained attention in online hair loss communities despite lacking FDA approval and adequate clinical evidence establishing its safety and effectiveness for androgenetic alopecia. Often promoted as a treatment that blocks androgen activity directly at the scalp, RU58841 raises important questions about systemic absorption and potential adverse effects.
In this episode of Spencer Kobren’s The Bald Truth, Kobren and Joe Tillman examine the concerns surrounding RU58841 and the risks of experimenting with inadequately studied treatments. The discussion highlights why topical application should not automatically be assumed to eliminate systemic exposure or guarantee safety.
Mark Normand’s Hair Transplant: What Should Patients Know?
As more public figures discuss hair transplant surgery, the procedure has become increasingly visible across social media and mainstream entertainment. But celebrity transformations rarely explain the medical considerations that determine whether transplantation is appropriate for an individual patient.
Using comedian Mark Normand’s hair transplant experience as a starting point, Spencer Kobren and Joe Tillman examine realistic expectations, appropriate surgical planning and the importance of preserving a finite donor supply. The discussion reinforces why natural, lasting results depend on the surgeon’s experience, clinical judgment and understanding of progressive hair loss.
Is PP405 a Hair Loss Breakthrough or Is the Hype Getting Ahead of the Science?
PP405, an experimental topical treatment being developed by Pelage Pharmaceuticals, has generated significant interest for its potential to reactivate dormant hair follicle stem cells and stimulate hair growth. Early clinical findings have been encouraging, but do they justify the excitement surrounding this investigational therapy?
In this episode of Spencer Kobren’s The Bald Truth, Kobren and Joe Tillman examine the science behind PP405, the limitations of preliminary clinical results and the difference between promising research and proven treatment effectiveness. The discussion considers whether PP405 represents meaningful progress toward treating androgenetic alopecia or another example of expectations outpacing the available evidence.
What Is the Future of Hair Loss Treatment?
Researchers continue to investigate new approaches to treating androgenetic alopecia and other forms of hair loss, including experimental medications, regenerative therapies and treatments targeting the biological mechanisms of follicular miniaturization. But which developments are supported by credible science, and how close are they to becoming available?
In this episode of Spencer Kobren’s The Bald Truth, Kobren and Joe Tillman explore emerging hair loss research and the challenges of separating meaningful scientific progress from exaggerated commercial claims. The discussion emphasizes why promising laboratory findings and early clinical results should not be mistaken for established, effective treatments.
Featured Articles
Hair Loss Research, Treatment Advances, Hair Transplant Surgery and Consumer Protection
Long-Term Hair Loss Planning: Thinking Beyond Your First Hair Transplant
Medically reviewed by Aron G. Nusbaum, M.D., FAAD – April 28, 2026 Introduction Hair
The Real Risks of Hair Transplant Surgery: What Patients Need to Know
Medically reviewed by Aron G. Nusbaum, M.D., FAAD – April 28, 2026 Introduction Hair